In addition, we find that the PMS1/PMS2 and RAD23A/ERCC6 mRNA ratios, indicative of MutLβ/MutLα and of global/translation NER ratios respectively, to be independent risk factors in this GBM patient population. The gene discussed is RAD23A; the disease is glioblastoma.